{"log_id": 6513446944795851825, "direction": 0, "words_result_num": 35, "words_result": [{"probability": {"variance": 9.2e-05, "average": 0.996619, "min": 0.951933}, "location": {"width": 917, "top": 119, "height": 48, "left": 206}, "words": "此药可抑制细胞色素P4503A4系统,因此可升高硝苯地平的血浆浓度而加强抗高血压"}, {"probability": {"variance": 0, "average": 0.999908, "min": 0.999848}, "location": {"width": 53, "top": 183, "height": 27, "left": 159}, "words": "疗效"}, {"probability": {"variance": 1e-06, "average": 0.99863, "min": 0.996884}, "location": {"width": 98, "top": 229, "height": 27, "left": 210}, "words": "西沙必利"}, {"probability": {"variance": 7.8e-05, "average": 0.997178, "min": 0.954587}, "location": {"width": 603, "top": 268, "height": 38, "left": 209}, "words": "西沙必利与硝苯地平合用时可使硝苯地平的血浆浓度升高"}, {"probability": {"variance": 0.000118, "average": 0.995444, "min": 0.93424}, "location": {"width": 913, "top": 310, "height": 46, "left": 209}, "words": "对细胞色素P4503A4系统有诱导作用的抗癫痫药物,例如苯妥英、卡马西平和苯巴比"}, {"probability": {"variance": 0, "average": 0.999348, "min": 0.999348}, "location": {"width": 28, "top": 374, "height": 28, "left": 161}, "words": "妥"}, {"probability": {"variance": 4e-06, "average": 0.998754, "min": 0.989721}, "location": {"width": 914, "top": 406, "height": 44, "left": 209}, "words": "苯妥英可诱导细胞色素P4503A4系统。与苯妥英合用时,硝苯地平的生物利用度降低"}, {"probability": {"variance": 6e-06, "average": 0.999018, "min": 0.988406}, "location": {"width": 960, "top": 454, "height": 43, "left": 162}, "words": "从而导致疗效下降。当两种药物合用时,需监测硝苯地平的临床疗效,必要时需增加硝苯地"}, {"probability": {"variance": 1.1e-05, "average": 0.998808, "min": 0.978172}, "location": {"width": 959, "top": 500, "height": 45, "left": 163}, "words": "平的剂量。如两种药物合用时已经增加了硝苯地平的剂量,停用苯妥英后应考虑减小硝苯地"}, {"probability": {"variance": 0, "average": 0.999806, "min": 0.99955}, "location": {"width": 95, "top": 561, "height": 28, "left": 163}, "words": "平的剂量"}, {"probability": {"variance": 3.8e-05, "average": 0.998319, "min": 0.961024}, "location": {"width": 914, "top": 594, "height": 43, "left": 210}, "words": "目前尚未进行硝苯地平与卡马西平或苯巴比妥是否有潜在相互作用的研究,但是因为卡"}, {"probability": {"variance": 2e-06, "average": 0.999313, "min": 0.992607}, "location": {"width": 959, "top": 641, "height": 46, "left": 163}, "words": "马西平和苯巴比妥均可诱导酶的活性,从而导致与硝苯地平结构相似的钙离子通道阻滞剂尼"}, {"probability": {"variance": 2e-06, "average": 0.998955, "min": 0.995638}, "location": {"width": 959, "top": 689, "height": 44, "left": 162}, "words": "莫地平的血药浓度降低,因此不能排除硝苯地平与卡马西平或苯巴比妥合用可降低硝苯地平"}, {"probability": {"variance": 0, "average": 0.999745, "min": 0.99837}, "location": {"width": 293, "top": 746, "height": 32, "left": 162}, "words": "的血药浓度,从而降低疗效"}, {"probability": {"variance": 0, "average": 0.999626, "min": 0.998567}, "location": {"width": 247, "top": 793, "height": 30, "left": 211}, "words": "受硝苯地平影响的药物"}, {"probability": {"variance": 0, "average": 0.999934, "min": 0.999898}, "location": {"width": 73, "top": 843, "height": 26, "left": 211}, "words": "降压药"}, {"probability": {"variance": 0.001547, "average": 0.936454, "min": 0.89663}, "location": {"width": 135, "top": 810, "height": 66, "left": 910}, "words": "医药分"}, {"probability": {"variance": 3e-05, "average": 0.99781, "min": 0.97391}, "location": {"width": 651, "top": 878, "height": 43, "left": 210}, "words": "硝苯地平与其它降压药合用会加强硝苯地平的降压作用,例如"}, {"probability": {"variance": 1e-06, "average": 0.998659, "min": 0.997679}, "location": {"width": 73, "top": 936, "height": 27, "left": 248}, "words": "利尿剂"}, {"probability": {"variance": 0, "average": 0.934801, "min": 0.934801}, "location": {"width": 75, "top": 888, "height": 78, "left": 929}, "words": "★"}, {"probability": {"variance": 0.000585, "average": 0.985968, "min": 0.931367}, "location": {"width": 154, "top": 982, "height": 27, "left": 251}, "words": "β-受体阻滞剂"}, {"probability": {"variance": 0.000219, "average": 0.992236, "min": 0.95932}, "location": {"width": 128, "top": 1031, "height": 27, "left": 249}, "words": "ACE抑制剂"}, {"probability": {"variance": 0.002948, "average": 0.971775, "min": 0.839379}, "location": {"width": 128, "top": 1076, "height": 28, "left": 249}, "words": "AT1-拮抗剂"}, {"probability": {"variance": 0.001858, "average": 0.978997, "min": 0.882763}, "location": {"width": 150, "top": 1122, "height": 30, "left": 247}, "words": "其它钙拮抗剂"}, {"probability": {"variance": 7e-06, "average": 0.998105, "min": 0.991896}, "location": {"width": 170, "top": 1169, "height": 28, "left": 284}, "words": "肾上腺素阻滞剂"}, {"probability": {"variance": 0.062686, "average": 0.821106, "min": 0.467033}, "location": {"width": 126, "top": 1148, "height": 58, "left": 646}, "words": "药销售"}, {"probability": {"variance": 0.035062, "average": 0.880813, "min": 0.477328}, "location": {"width": 230, "top": 1215, "height": 50, "left": 249}, "words": "PDES抑伟剂 PHARM AC"}, {"probability": {"variance": 0, "average": 0.87431, "min": 0.87431}, "location": {"width": 44, "top": 1202, "height": 38, "left": 596}, "words": "从"}, {"probability": {"variance": 0.045892, "average": 0.8463, "min": 0.386697}, "location": {"width": 251, "top": 1250, "height": 59, "left": 269}, "words": "基多巴环不球制药"}, {"probability": {"variance": 0.003807, "average": 0.98694, "min": 0.614518}, "location": {"width": 914, "top": 1300, "height": 43, "left": 212}, "words": "硝苯地平与B受体阻滞剂同时使用时,因为已知个别病例有心衰恶化的情况,必须对患"}, {"probability": {"variance": 2e-06, "average": 0.998989, "min": 0.996379}, "location": {"width": 122, "top": 1359, "height": 30, "left": 166}, "words": "者严格监测"}, {"probability": {"variance": 0, "average": 0.999467, "min": 0.999127}, "location": {"width": 73, "top": 1408, "height": 27, "left": 214}, "words": "地高辛"}, {"probability": {"variance": 4e-06, "average": 0.999026, "min": 0.991686}, "location": {"width": 912, "top": 1441, "height": 44, "left": 215}, "words": "与硝苯地平同时使用时会导致地高辛清除率降低,从而增加了地高辛的血药浓度。因此"}, {"probability": {"variance": 1e-05, "average": 0.998712, "min": 0.98585}, "location": {"width": 843, "top": 1491, "height": 42, "left": 166}, "words": "应监测其血药浓度防止药物过量,必要时可根据地高辛血药浓度减少其用药剂量"}, {"probability": {"variance": 1e-06, "average": 0.998512, "min": 0.997973}, "location": {"width": 72, "top": 1549, "height": 28, "left": 215}, "words": "奎尼丁"}], "language": 3}